J.-P. Briand

4.8k citations

33 papers · 3.0k · 3 hit papers · h-index 22

Impact in

Microbiology top 1%
- Antimicrobial Peptides and Activities
Virology top 5%

Papers in

Molecular Biology 16
- Glycosylation and Glycoproteins Research 3
Immunology 10
- T-cell and B-cell Immunology 3
- Immune Cell Function and Interaction 3
- Immunotherapy and Immune Responses 3

Co-authors: Sylviane Muller (13 shared papers)Alberto Bianco (4 shared papers)M.H.V. Van Regenmortel (8 shared papers)Kostas Kostarelos (2 shared papers)Giorgia Pastorin (2 shared papers)Olivier Chaloin (2 shared papers)Johan Hoebeke (1 shared paper)Ravi Singh (1 shared paper)
Journals: Journal of Biological Chemistry (3 papers)Journal of Immunological Methods (3 papers)The Journal of Immunology (2 papers)Vaccine (2 papers)Biochimica et Biophysica Acta (BBA) - Bioenergetics (1 paper)
Partner nations: France United Kingdom Sweden

In The Last Decade

J.-P. Briand

33 papers receiving 2.9k citations

J.-P. Briand's Hit Papers

align trajectories log scale

Functionalized Carbon Nanotubes Are Non-Cytotoxic and Preserve the Functionality of Primary Immune Cells 2006 · 542 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2006 Nano Letters
2005 Journal of the American Chemical Society
1996 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by J.-P. Briand

Since Specialization

Citations

This map shows the geographic impact of J.-P. Briand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-P. Briand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-P. Briand more than expected).

Fields of papers citing papers by J.-P. Briand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-P. Briand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-P. Briand. The network helps show where J.-P. Briand may publish in the future.

Co-authors

The 25 scholars most cited alongside J.-P. Briand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J.-P. Briand Line = papers co-authored together J.-P. Briand links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Binding and Condensation of Plasmid DNA onto Functionalized Carbon Nanotubes: Toward the Construction of Nanotube-Based Gene Delivery Vectors Journal of the American Chemical Society ·Ravi Singh, Davide Pantarotto, David McCarthy, Olivier Chaloin, Johan Hoebeke, Charalambos D. Partidos, J.-P. Briand, (unknown), Alberto Bianco, Kostas Kostarelos Hit paper breakdown →	2005	561
2	Functionalized Carbon Nanotubes Are Non-Cytotoxic and Preserve the Functionality of Primary Immune Cells Nano Letters ·Hélène Dumortier, Stéphanie Lacotte, Giorgia Pastorin, Riccardo Marega, Wei Wu, Davide Bonifazi, J.-P. Briand, (unknown), Sylviane Muller, Alberto Bianco Hit paper breakdown →	2006	542
3	Double functionalisation of carbon nanotubes for multimodal drug delivery Chemical Communications ·Giorgia Pastorin, Wei Wu, Sébastien Wieckowski, J.-P. Briand, Kostas Kostarelos, (unknown), Alberto Bianco	2006	308
4	Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides. Proceedings of the National Academy of Sciences ·Pascale Fehlbaum, Philippe Bulet, Sergey Chernysh, J.-P. Briand, J P Roussel, L. Letellier, Charles Hétru, Jules A. Hoffmann Hit paper breakdown →	1996	274
5	Synthetic peptides as antigens: Pitfalls of conjugation methods Journal of Immunological Methods ·J.-P. Briand, Sylviane Muller, M.H.V. Van Regenmortel	1985	252
6	The Anti-HIV Cytokine Midkine Binds the Cell Surface-expressed Nucleolin as a Low Affinity Receptor Journal of Biological Chemistry ·Elias A. Said, Bernard Krust, Sébastien Nisole, Josette Svab, J.-P. Briand, Ara G. Hovanessian	2002	120
7	Modulation of deregulated chaperone-mediated autophagy by a phosphopeptide Autophagy ·Christophe Macri, Fengjuan Wang, Inmaculada Tasset, Nicolas Schall, Nicolas Pagé, J.-P. Briand, Ana María Cuervo, Sylviane Muller	2015	83
8	Monoclonal antibodies as probes of the antigenic structure of tobacco mosaic virus. The EMBO Journal ·(unknown), J.-P. Briand, M.H.V. Van Regenmortel	1982	81
9	A novel receptor – ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu BMC Microbiology ·Monique Barel, Ara G. Hovanessian, Karin Lederballe Meibom, J.-P. Briand, Marion Dupuis, Alain Charbit	2008	80
10	The Anti-HIV Pseudopeptide HB-19 Forms a Complex with the Cell-surface-expressed Nucleolin Independent of Heparan Sulfate Proteoglycans Journal of Biological Chemistry ·Sébastien Nisole, Bernard Krust, Christian Callebaut, Gilles Guichard, Sylviane Muller, J.-P. Briand, Ara G. Hovanessian	1999	73
11	Application and limitations of the multiple antigen peptide (MAP) system in the production and evaluation of anti-peptide and anti-protein antibodies Journal of Immunological Methods ·J.-P. Briand, Christine Barin, Marc H.V. Van Regenmortel, Sylviane Muller	1992	71
12	The Caveolin-1 Binding Domain of HIV-1 Glycoprotein gp41 Is an Efficient B Cell Epitope Vaccine Candidate against Virus Infection Immunity ·Ara G. Hovanessian, J.-P. Briand, Elias A. Said, Josette Svab, Stéphane Ferris, Hayet Dali, Sylviane Muller, Claude Des̀granges, Bernard Krust	2004	58
13	Immunochemical studies of tobacco mosaic virus—VI. Attempts to localize viral epitopes with monoclonal antibodies Molecular Immunology ·Danièle Altschuh, (unknown), J.-P. Briand, M.H.V. Van Regenmortel	1985	55
14	A lipoyl synthetic octadecapeptide of dihydrolipoamide acetyltransferase specifically recognized by anti-M2 autoantibodies in primary biliary cirrhosis The Journal of Immunology ·Nadine Tuaillon, Claire André, J.-P. Briand, Edward Penner, S. Muller	1992	47
15	Epitope mapping with synthetic peptides of 52-kD SSA/Ro protein reveals heterogeneous antibody profiles in human autoimmune sera Clinical & Experimental Immunology ·Vincent Ricchiuti, J.-P. Briand, Olivier Meyer, David Isenberg, G PRUIJNJ, Sylviane Muller	1994	45
16	Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis PLoS ONE ·Jürgen Dieker, Jo H. M. Berden, Marinka A.H. Bakker, J.-P. Briand, Sylviane Muller, Reinhard Voll, Christopher Sjöwall, Martin Herrmann, Luuk B. Hilbrands, Johan van der Vlag	2016	41
17	Autoantibodies Reacting with Poly(ADP-Ribose) and with a Zinc-Finger Functional Domain of Poly(ADP-Ribose) Polymerase Involved in the Recognition of Damaged DNA Clinical Immunology and Immunopathology ·Sylviane Muller, J.-P. Briand, Sarah Barakat, Jean Lagueux, Guy G. Poirier, Gilbert de Murcia, David Isenberg	1994	36
18	Two pairs of oppositely charged amino acids from Jun and Fos confer heterodimerization to GCN4 leucine zipper. Journal of Biological Chemistry ·Matthias John, J.-P. Briand, Michèle Granger‐Schnarr, Manfred Schnarr	1994	33
19	Zinc is an essential cofactor for recognition of the DNA binding domain of poly(ADP-ribose) polymerase by antibodies in autoimmune rheumatic and bowel diseases Arthritis & Rheumatism ·Patrice Decker, J.-P. Briand, Gilbert de Murcia, Ron W. Pero, David Isenberg, Sylviane Muller	1998	29
20	The HB-19 Pseudopeptide 5[Kpsi(CH ₂ N)PR]-TASP Inhibits Attachment of T Lymphocyte- and Macrophage-Tropic HIV to Permissive Cells AIDS Research and Human Retroviruses ·Sébastien Nisole, Bernard Krust, (unknown), Alberto Bianco, Nabila Seddiki, S Loaec, Christian Callebaut, Gilles Guichard, Sylviane Muller, J.-P. Briand, Ara G. Hovanessian	2000	25

About J.-P. Briand

J.-P. Briand is a scholar working on Molecular Biology, Immunology, Radiology, Nuclear Medicine and Imaging, Epidemiology and Virology, having authored 33 papers that have together received 3.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), HIV Research and Treatment (4 papers), Glycosylation and Glycoproteins Research (3 papers), T-cell and B-cell Immunology (3 papers), Transgenic Plants and Applications (3 papers), Immune Cell Function and Interaction (3 papers), Immunotherapy and Immune Responses (3 papers) and Carbon Nanotubes in Composites (3 papers). The work is most often cited by research in Microbiology (271 citations), Virology (97 citations), Immunology (410 citations), Materials Chemistry (934 citations) and Biomedical Engineering (821 citations). J.-P. Briand has collaborated with scholars based in France, United Kingdom and Sweden. Frequent co-authors include Sylviane Muller, Alberto Bianco, M.H.V. Van Regenmortel, Kostas Kostarelos, Giorgia Pastorin, Olivier Chaloin, Johan Hoebeke, Ravi Singh, Charalambos D. Partidos and Davide Pantarotto. Their work appears in journals such as Journal of Biological Chemistry, Journal of Immunological Methods, The Journal of Immunology, Vaccine and Biochimica et Biophysica Acta (BBA) - Bioenergetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

J.-P. Briand

Impact in

Papers in i

In The Last Decade

J.-P. Briand

J.-P. Briand's Hit Papers

Peers

Countries citing papers authored by J.-P. Briand

Fields of papers citing papers by J.-P. Briand

All Works

About J.-P. Briand

Explore authors with similar magnitude of impact

Papers in